Bitter Orange for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Bitter Orange for Health & Longevity

Created on 08/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

One plant, three different products. The peel extract shifts which fuel the body burns during moderate exercise, without meaningful weight change. Inhaled blossom oil has the strongest human evidence — lower anxiety and pain. The juice blocks a gut enzyme that limits how much of several medicines reaches the blood. Safety is unsettled; product quality is the weakest link. (Full Review)

Protocol

Standard supplement dosing
10–20 mg p-synephrine, three times daily
From extract standardised to 6–30% content. Acute single doses of about 50 mg are also used.
Exercise protocol
2–3 mg/kg, 60 minutes before
Roughly 150–250 mg, before cycling at 30–80% of peak oxygen uptake.
Best time of day
Morning
With a 3-hour half-life, a dose after mid-afternoon remains pharmacologically active at bedtime.
Time to effect
Metabolic effects
60–90 minutes
Acute after a single dose and gone within 12 hours. No cumulative effect has been demonstrated.
Post-exercise energy expenditure
Through 30 minutes
Raised after resistance training, with fat oxidation favoured at 25–30 minutes.
Menopausal symptom burden
Five days
Twice-daily neroli inhalation improved the physical domain of menopausal quality of life.

Benefits

Contraindications
  • Uncontrolled hypertension (resting pressure ≥140/90 mmHg)
  • Recent myocardial infarction (<90 days) or unstable angina
  • Known arrhythmia, or corrected QT interval >470 ms in men or >480 ms in women
  • Pregnancy and lactation, at any dose or form
  • Untreated hyperthyroidism, or thyrotropin below 0.4 mIU/L
  • Narrow-angle glaucoma and symptomatic benign prostatic hyperplasia
  • Athletes governed by National Collegiate Athletic Association rules
  • Monoamine oxidase inhibitors (phenelzine, tranylcypromine, selegiline, rasagiline, linezolid), currently or within 14 days
Key Interactions
  • CYP3A4 substrates from whole fruit or juice (felodipine, nifedipine, simvastatin, atorvastatin, tacrolimus, midazolam)
  • Colchicine and dextromethorphan
  • Antihypertensives and beta-blockers (metoprolol, atenolol, amlodipine, lisinopril)
  • Over-the-counter decongestants (pseudoephedrine, phenylephrine) and stimulant cold remedies
  • Caffeine, guarana, yohimbine, higenamine, and synephrine-containing pre-workouts
  • Thyroid hormone (levothyroxine, liothyronine)
  • Cold-water immersion, sauna, and high-intensity interval sessions (same 3-hour window)
    •

Risk & Side Effects

  • High: Elevated blood pressure and heart rate; intestinal CYP3A4 inhibition by the whole fruit and juice
  • Medium: Serious cardiovascular events with multi-stimulant products; product adulteration with prohibited synthetic stimulants
  • Low: Anti-doping sanction risk; palpitations, headache, and insomnia; photosensitivity from topical blossom and peel oil
  • Speculative: Reproductive and lactation effects; proarrhythmia at supraphysiological concentrations

Monitoring

Marker Target Why
Resting blood pressure <120/80 mmHg Detects the dose-limiting adrenergic effect
Resting heart rate 50–70 bpm Tracks sympathetic drive directly
Heart rate variability No established target; track change from own baseline Falling values signal accumulating adrenergic and training load
Fasting glucose 75–90 mg/dL Stimulants can raise circulating glucose, and one combination trial showed glucose sparing at rest
HbA1c 4.8–5.4% Confirms no drift in glucose control over months of use
hs-CRP <1.0 mg/L Baseline inflammation modifies cardiovascular risk from any pressure rise
ALT <25 U/L (men), <20 U/L (women) Screens liver stress, since multi-ingredient fat burners carry liver-damaging ingredients
TSH 0.5–2.0 mIU/L Rules out thyroid overactivity that an adrenergic agent would unmask
QTc interval <440 ms (men), <460 ms (women) Identifies the electrical substrate for the theoretical arrhythmia risk
Body composition No established target; track change from own baseline Tests the marketed claim against the pooled trial finding of no change

Cadence: Home blood pressure and heart rate twice weekly for the first four weeks; metabolic panel rechecked at 12 weeks; testing thereafter every 6–12 months while use continues. At least one pressure reading falls 2 hours after a dose, when exposure peaks.

Qualitative Assessment

  • Sleep onset latency and night waking frequency, especially after any dose taken later than mid-afternoon
  • Palpitations, chest discomfort, or a sense of restless overstimulation at rest
  • Perceived exertion at a fixed training workload, which should be unchanged or slightly easier
  • Appetite and time to first hunger after waking
  • Headache frequency, jitteriness, and afternoon energy crash
  • Subjective anxiety and evening calm, which is the relevant endpoint for the inhaled blossom oil rather than the extract
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.